Never miss anything again: The industrial-production-worldwide.com newsletter regularly presents the global highlights of industrial production worldwide, Yes, I would like to subscribe to the industrial-production-worldwide.com newsletter - revocable:



Please confirm your newsletter subscription in the email you will receive shortly. We handle your data in accordance with the current General Data Protection Regulation (GDPR). You can unsubscribe from the newsletter at any time with a click of the mouse (= withdrawal of consent).
Curevac
 
The acquisition expands Curevac's capacity and expertise to further expand its oncology strategy for new therapies that enable patients' immune systems to fight cancer.
Curevac is acquiring privately held Frame Cancer Therapeutics, which focuses on advanced genomics and bioinformatics to identify both unique and common neoantigens for various cancers. "Embedding Frame's technology and expertise into Curevac's oncology research complements our ability to identify and validate promising neoantigens for our mRNA cancer vaccine programs," emphasized Franz-Werner Haas...
Read more